206 related articles for article (PubMed ID: 35422057)
1. Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.
Mintz R; Wang M; Xu S; Colditz GA; Markovic C; Toriola AT
Breast Cancer Res; 2022 Apr; 24(1):28. PubMed ID: 35422057
[TBL] [Abstract][Full Text] [Related]
2. Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.
Toriola AT; Appleton CM; Zong X; Luo J; Weilbaecher K; Tamimi RM; Colditz GA
Cancer Prev Res (Phila); 2018 Dec; 11(12):789-796. PubMed ID: 30352839
[TBL] [Abstract][Full Text] [Related]
3. Plasma Growth Factor Gene Expression and Mammographic Breast Density in Postmenopausal Women.
Akinjiyan FA; Adams A; Xu S; Wang M; Toriola AT
Cancer Prev Res (Phila); 2022 Jun; 15(6):391-398. PubMed ID: 35288741
[TBL] [Abstract][Full Text] [Related]
4. Serum osteoprotegerin levels and mammographic density among high-risk women.
Moran O; Zaman T; Eisen A; Demsky R; Blackmore K; Knight JA; Elser C; Ginsburg O; Zbuk K; Yaffe M; Narod SA; Salmena L; Kotsopoulos J
Cancer Causes Control; 2018 Jun; 29(6):507-517. PubMed ID: 29679262
[TBL] [Abstract][Full Text] [Related]
5. Adiposity Change Over the Life Course and Mammographic Breast Density in Postmenopausal Women.
Han Y; Berkey CS; Herman CR; Appleton CM; Alimujiang A; Colditz GA; Toriola AT
Cancer Prev Res (Phila); 2020 May; 13(5):475-482. PubMed ID: 32102947
[TBL] [Abstract][Full Text] [Related]
6. Medication use and mammographic breast density.
Han Y; Lee CT; Xu S; Mi X; Phillip CR; Salazar AS; Rakhmankulova M; Toriola AT
Breast Cancer Res Treat; 2021 Sep; 189(2):585-592. PubMed ID: 34196899
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mammographic density among women with a strong family history of breast cancer.
Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
[TBL] [Abstract][Full Text] [Related]
8. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
[TBL] [Abstract][Full Text] [Related]
9. Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women.
McCormack VA; Dowsett M; Folkerd E; Johnson N; Palles C; Coupland B; Holly JM; Vinnicombe SJ; Perry NM; dos Santos Silva I
Breast Cancer Res; 2009; 11(3):R38. PubMed ID: 19545414
[TBL] [Abstract][Full Text] [Related]
10. Endogenous sex hormone levels and mammographic density among postmenopausal women.
Tamimi RM; Hankinson SE; Colditz GA; Byrne C
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2641-7. PubMed ID: 16284390
[TBL] [Abstract][Full Text] [Related]
11. Increased breast tissue receptor activator of nuclear factor-κB ligand (RANKL) gene expression is associated with higher mammographic density in premenopausal women.
Toriola AT; Dang HX; Hagemann IS; Appleton CM; Colditz GA; Luo J; Maher CA
Oncotarget; 2017 Sep; 8(43):73787-73792. PubMed ID: 29088745
[TBL] [Abstract][Full Text] [Related]
12. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
13. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density.
van Duijnhoven FJ; Peeters PH; Warren RM; Bingham SA; Uitterlinden AG; van Noord PA; Monninkhof EM; Grobbee DE; van Gils CH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):462-7. PubMed ID: 16537702
[TBL] [Abstract][Full Text] [Related]
14. Changes in adiposity over the life course and gene expression in postmenopausal women.
Han Y; Colditz GA; Toriola AT
Cancer Med; 2022 Jul; 11(13):2699-2710. PubMed ID: 35304837
[TBL] [Abstract][Full Text] [Related]
15. Hormonal determinants of mammographic density and density change.
Gabrielson M; Azam S; Hardell E; Holm M; Ubhayasekera KA; Eriksson M; Bäcklund M; Bergquist J; Czene K; Hall P
Breast Cancer Res; 2020 Aug; 22(1):95. PubMed ID: 32847607
[TBL] [Abstract][Full Text] [Related]
16. Milk intake and mammographic density in premenopausal women.
Han Y; Zong X; Li Y; Colditz GA; Toriola AT
Breast Cancer Res Treat; 2019 Feb; 174(1):249-255. PubMed ID: 30456438
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.
Rudolph A; Fasching PA; Behrens S; Eilber U; Bolla MK; Wang Q; Thompson D; Czene K; Brand JS; Li J; Scott C; Pankratz VS; Brandt K; Hallberg E; Olson JE; Lee A; Beckmann MW; Ekici AB; Haeberle L; Maskarinec G; Le Marchand L; Schumacher F; Milne RL; Knight JA; Apicella C; Southey MC; Kapuscinski MK; Hopper JL; Andrulis IL; Giles GG; Haiman CA; Khaw KT; Luben R; Hall P; Pharoah PD; Couch FJ; Easton DF; Dos-Santos-Silva I; Vachon C; Chang-Claude J
Breast Cancer Res; 2015 Aug; 17(1):110. PubMed ID: 26275715
[TBL] [Abstract][Full Text] [Related]
18. Associations of Vitamins and Related Cofactor Metabolites with Mammographic Breast Density in Premenopausal Women.
Matthew KA; Getz KR; Jeon MS; Luo C; Luo J; Toriola AT
J Nutr; 2024 Feb; 154(2):424-434. PubMed ID: 38122846
[TBL] [Abstract][Full Text] [Related]
19. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
20. Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.
Rice MS; Tworoger SS; Bertrand KA; Hankinson SE; Rosner BA; Feeney YB; Clevenger CV; Tamimi RM
Breast Cancer Res Treat; 2015 Jan; 149(1):245-53. PubMed ID: 25503962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
